Article

Taylor, P A; Miles, E; Hoffmann, L; Kelly, S M; Kry, S F; Moller, D S; Palmans, H; Akbarov, K; Aznar, M C; Clemantel, E; Corning, C; Effeney, R; Healy, B; Moore, A; Nakamura, M; Petel, S; Shaw, M; Stock, M; Lehmann, J; Clark, C H (2023) Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison. Radiotherapy and Oncology, 182. 109494

Lehmann, J; Hussein, M; Barry, M A; Siva, S; Moore, A; Chu, M; Diez, P; Eaton, D J; Harwood, J; Lonski, P; Claridge Mackonis, E; Meehan, C; Patel, R; Ray, X; Shaw, M; Shepherd, J; Smyth, G; Standen, T S; Subramanian, B; Clark, C H (2022) SEAFARER – A new concept for validating radiotherapy patient specific QA for clinical trials and clinical practice. Radiotherapy and Oncology, 171. pp. 121-128.

Mir, R; Kelly, S M; Xiao, Y; Moore, A; Clark, C H; Clementel, E; Corning, C; Ebert, M; Hoskin, P; Hurkmans, C W; Ishikura, S; Kristensen, I; Kry, S F; Lehmann, J; Michalski, J M; Monti, A F; Nakamura, M; Thompson, K; Yang, H; Zubizarreta, E; Andratschke, N; Miles, E (2020) Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines. Radiotherapy and Oncology, 150. pp. 30-39. ISSN 01678140

Lehmann, J; Hussein, M; Standen, T; Siva, S; Moore, A; Subramanian, B; Barnes, M; Greer, P; Clark, C (2019) Towards safe delivery of radiation therapy-assessment of the sensitivity of clinically used patient-specific quality assurance methods. ASIA-Pacific Journal of Clinical Oncology, 15 (S7). p. 23.